Inotiv, Inc. (NASDAQ:NOTV) CEO Robert Jr. Leasure Sells 73,617 Shares

Inotiv, Inc. (NASDAQ:NOTV) CEO Robert Jr. Leasure sold 73,617 shares of the stock in a transaction dated Tuesday, February 18th. The stock was sold at an average price of $3.82, for a total transaction of $281,216.94. Following the sale, the chief executive officer now directly owns 956,592 shares in the company, valued at $3,654,181.44. This represents a 7.15 % decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through this link.

Robert Jr. Leasure also recently made the following trade(s):

• On Friday, January 31st, Robert Jr. Leasure sold 22,700 shares of Inotiv stock. The stock was sold at an average price of $4.15, for a total transaction of $94,205.00.

Inotiv Stock Up 9.0 %

Shares of NOTV opened at $4.25 on Friday. The stock has a market capitalization of $143.31 million, a PE ratio of -0.92 and a beta of 3.58. Inotiv, Inc. has a 1 year low of $1.23 and a 1 year high of $11.42. The company has a debt-to-equity ratio of 2.31, a quick ratio of 1.28 and a current ratio of 1.57. The company’s 50-day simple moving average is $4.36 and its 200-day simple moving average is $2.94.

Inotiv (NASDAQ:NOTV) last issued its quarterly earnings results on Wednesday, February 5th. The company reported ($0.42) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.32) by ($0.10). Inotiv had a negative return on equity of 15.41% and a negative net margin of 25.40%. Analysts forecast that Inotiv, Inc. will post -0.79 earnings per share for the current fiscal year.

Institutional Trading of Inotiv

Several hedge funds have recently added to or reduced their stakes in NOTV. Geode Capital Management LLC raised its holdings in Inotiv by 7.7% in the third quarter. Geode Capital Management LLC now owns 250,895 shares of the company’s stock valued at $427,000 after acquiring an additional 18,039 shares in the last quarter. Thurston Springer Miller Herd & Titak Inc. raised its holdings in Inotiv by 612.5% in the fourth quarter. Thurston Springer Miller Herd & Titak Inc. now owns 127,257 shares of the company’s stock valued at $527,000 after acquiring an additional 109,397 shares in the last quarter. KPP Advisory Services LLC raised its holdings in Inotiv by 15.8% in the fourth quarter. KPP Advisory Services LLC now owns 275,267 shares of the company’s stock valued at $1,140,000 after acquiring an additional 37,549 shares in the last quarter. Vantage Point Financial LLC acquired a new stake in Inotiv in the fourth quarter valued at approximately $1,393,000. Finally, Calamos Advisors LLC acquired a new stake in Inotiv in the fourth quarter valued at approximately $275,000. Institutional investors and hedge funds own 18.17% of the company’s stock.

About Inotiv

Inotiv, Inc provides nonclinical and analytical drug discovery and development services to the pharmaceutical and medical device industries. It operates through two segment: Discovery and Safety Assessment (DSA), and Research Models and Services (RMS). The DMS segment manufactured scientific instruments for life sciences research and the related software for use by pharmaceutical companies, universities, government research centers, and medical research institutions under the Company's BASi product line.